Tempus AI, Inc. (TEM)
NASDAQ: TEM · Real-Time Price · USD
63.44
+1.50 (2.42%)
Sep 3, 2026, 12:23 PM EDT - Market open
Tempus AI Employees
Tempus AI had 3,800 employees as of December 31, 2025. The number of employees increased by 1,400 or 58.33% compared to the previous year.
Employees
3,800
Change (1Y)
1,400
Growth (1Y)
58.33%
Revenue / Employee
$376,847
Profits / Employee
-$66,954
Market Cap
11.45B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3,800 | 1,400 | 58.33% |
| Dec 31, 2024 | 2,400 | 100 | 4.35% |
| Dec 31, 2023 | 2,300 | 348 | 17.83% |
| Dec 31, 2022 | 1,952 | 385 | 24.57% |
| Dec 31, 2021 | 1,567 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BrightSpring Health Services | 23,500 |
| Veeva Systems | 7,928 |
| Omnicell | 3,485 |
| HealthEquity | 2,814 |
| Waystar Holding | 1,700 |
| Privia Health Group | 1,226 |
| 10x Genomics | 1,178 |
| Doximity | 880 |
TEM News
- 1 day ago - Why Moderna's Cancer Vaccine Matters to Investors - ETF Trends
- 1 day ago - Cantor Fitzgerald bullish on Tempus AI, initiates with an Overweight - TheFly
- 1 day ago - Tempus AI initiated with an Overweight at Cantor Fitzgerald - TheFly
- 2 days ago - Tempus AI upgraded to Overweight from Neutral at Piper Sandler - TheFly
- 7 days ago - Top Performing Leveraged/Inverse ETFs: 08/23/2026 - ETF Trends
- 10 days ago - Tempus AI receives FDA clearance for Tempus ECG-PH - TheFly
- 10 days ago - Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs - Business Wire
- 14 days ago - Tempus AI rises 10.2% - TheFly